Top Story

NOMI: Nitric oxide did not reduce infarct size in STEMI

September 16, 2014

BARCELONA, Spain — Inhaled nitric oxide during PCI for STEMI failed to reduce infarct size in the total population but showed some interaction with nitroglycerin, according to findings from the NOMI trial presented here.

Stefan P. Janssens, MD, PhD, said that inhaling nitric oxide has demonstrated the capacity to reduce infarct size and improve left ventricular function and structural recovery after PCI for STEMI.

In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to research published in…
Meeting News Coverage

Abnormal ECG, aortic regurgitation common among centenarians

September 12, 2014
BARCELONA, Spain — A study of centenarians showed that the majority had an abnormal ECG and approximately half had aortic regurgitation, according to findings…
figure In the Journals

CDC: Children’s sodium intake higher than recommended

September 11, 2014
Sodium intake among school-aged children in the United States is higher than CDC recommendations, according to a recent MMWR report.More than 90% of children in the…
CME
figure

Managing Antiplatelet Therapy in Patients on Proton Pump Inhibitors: Understanding Drug Interactions and Cardiovascular Implications

This activity is supported by an educational grant from Takeda.

Patients receiving antiplatelet therapy are at an increased risk of gastrointestinal bleeding. Proton pump inhibitors…
More »
Meeting News Coverage Video
figure

Dominic A. Sica, MD, on treatment for resistant hypertension

June 6, 2014
NEW YORK — In this video, Dominic A. Sica, MD, chairman of clinical pharmacology and hypertension at the…
More »
CME
figure

Risk Management in the Cardiovascular Disease Arena: Focus on Glycemic Control

This activity is supported by an educational grant from Genentech.

Among the multiple comorbidities and complications that are associated with type 2 diabetes mellitus (T2DM)…
More »

Filter By:

Meeting News Coverage

NOMI: Nitric oxide did not reduce infarct size in STEMI

September 16, 2014
BARCELONA, Spain — Inhaled nitric oxide during PCI for STEMI failed to reduce infarct size in the total population but showed some interaction…
In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to…
Meeting News Coverage

Abnormal ECG, aortic regurgitation common among centenarians

September 12, 2014
BARCELONA, Spain — A study of centenarians showed that the majority had an abnormal ECG and approximately half had aortic regurgitation…
figure In the Journals

CDC: Children’s sodium intake higher than recommended

September 11, 2014
Sodium intake among school-aged children in the United States is higher than CDC recommendations, according to a recent MMWR report.More than 90% of…
FDA News Perspective

FDA approves Contrave for chronic weight management

September 11, 2014
The FDA granted approval for naltrexone hydrochloride and bupropion hydrochloride extended-release tablets for adults to use, in conjunction with…
figure Meeting News Coverage Perspective

MITOCARE: Investigational agent failed to prevent reperfusion injury in STEMI

September 10, 2014
BARCELONA, Spain — Investigational drug TRO40303 failed to best placebo in reducing infarct size in a cohort of patients treated with primary…
Meeting News Coverage

IBIS-4: High-dose rosuvastatin reduced coronary atherosclerosis in STEMI patients

September 10, 2014
BARCELONA, Spain — One year of treatment with high-intensity rosuvastatin was associated with a significant reduction of coronary…
In the Journals

Statins before diabetes diagnosis did not increase microvascular disease risk

September 10, 2014
Patients treated with statins before being diagnosed with diabetes are not at increased risk for microvascular disease, according to data published…
FDA News

FDA panel: Randomized controlled trials should not be required for polypill approval

September 10, 2014
The FDA’s Cardiovascular and Renal Drugs Advisory Committee told the agency today that a randomized controlled trial should not be required for…
In the Journals

Long-term statin therapy benefited children with familial hypercholesterolemia

September 9, 2014
Patients with familial hypercholesterolemia who had long-term statin therapy initiated in childhood had normalized progression of carotid…
More Headlines »